The Danish pharmaceutical company Novo Nordisk has seen its shares decline by nearly 50 per cent over the past year, following a warning of a significant drop in profits and
All posts tagged in pharmaceuticals
44Articles
GSK is evaluating potential cost-saving measures and manufacturing adjustments in Europe as it aims to invest in the launch of new products while moving away from older legacy drugs. City
AstraZeneca has announced plans to invest $15 billion in China by 2030, aiming to enhance its manufacturing capabilities and expand research and development. This announcement comes during a visit by
Novo Nordisk has secured a significant regulatory victory, following the United States Food and Drug Administration’s approval of its new weight loss pill containing semaglutide. The decision delivers the Danish
Illicit Weight Loss Drug Supplier Alluvi Persists with Unlicensed Sales After High Profile MHRA Raid
A company linked to the globe’s largest known seizure of illicit weight-loss medications remains active in the UK market despite regulatory intervention. Alluvi, the firm in question, continues to distribute
The United Kingdom is poised to provide NHS patients with access to new medicines previously deemed unaffordable under a sweeping agreement with the United States. Under the deal, NHS expenditure
AstraZeneca has recorded its highest quarterly revenue to date, achieving a ten per cent increase and surpassing analyst expectations. The FTSE 100 pharmaceutical group announced total third quarter revenue had
The powerful Novo Nordisk Foundation, the largest shareholder in pharmaceutical giant Novo Nordisk, has executed a dramatic boardroom takeover after a sharp disagreement about the company’s strategic direction. The move,
Sir Keir Starmer is preparing to overhaul NHS value for money protocols in a high-stakes move that could see Britain pour billions more into pharmaceutical spending. This comes amid escalating
The Prime Minister recently convened with Sir Pascal Soriot, the chief executive of AstraZeneca, at Downing Street to discuss the government’s efforts to bolster UK capital markets. This meeting came
Billions of pounds were added to the market value of British and global pharmaceutical companies on Wednesday following a major relief rally prompted by the Trump administration’s latest stance on
AstraZeneca, one of Britain’s leading pharmaceutical giants, has announced its intention to secure a direct listing on the New York Stock Exchange in a strategic move aimed at strengthening its
The UK pharmaceutical sector, long celebrated as a linchpin of the British economy, now faces an unprecedented crisis following the imposition of sweeping new tariffs by Donald Trump. In a
Moderna has marked a significant milestone in the UK pharmaceuticals landscape by launching a £150m manufacturing and research facility in Oxfordshire. The ribbon-cutting ceremony, attended by Moderna’s chief executive Stéphane
Bristol Myers Squibb BMS has issued a pointed demand for the NHS to fund a greater share of pharmaceutical innovation calling for the UK to pay what it describes as
Novo Nordisk, headquartered in Copenhagen, has seen its shares surge by more than 6 per cent after unveiling promising results from a late-stage clinical trial of its new anti-obesity tablet.
